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Disease managementAbstract Research which concerns the usefulness of Probiotics show increasing interest based on
the rise of their publications, products and the awareness of the public of their beneﬁts. There is
increasing interest concerning Probiotics from the public, researchers, governmental organizations
(such as the WHO/FAO) and medicinal and food companies. Probiotics means ‘‘let good microbes
work for you in different ﬁelds get their beneﬁts and take a rest’’. Such work will include, food
digestion, production of useful products to destroy the bad microbes, complement the functions
of the missed digestive enzymes (due to missed or defective genes), and to maintain the digestive
system’s pH, and so on. Probiotics will augment the efﬁciency of our biological fermentors, the
digestive system. Many authors have described the history and the progress of Probiotics and their
different applications. In this review, we will focus mainly on three points, health improvement,
infection control and disease management, which could be eliminated by the use of different types
of direct uses of Probiotics or by the use of foods containing Probiotics.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.
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It became clear that intestinal microﬂora had metabolic func-
tions, such as fermenting indigestible dietary residues and
endogenous mucus, saving of energy, production of vitamin
K, and absorption of ions (O’Sullivan et al., 1992). Probiotics
have roles in epithelial cell proliferation and differentiation,
and the development and the homeostasis of the immune sys-
tem (Cammarota et al., 2009). Probiotics are not an invention
but existed in our traditional foods such as beverages, salty
ﬁshes, yogurt, different types of cheeses and so on since olden
times (Amara, 2012). Such food structures contain different
types of useful bacteria. It might be that the ﬁrst real use of food
containing Probiotics was fermented milk (Hosono, 1992). Hu-
mans learned that fermented milk has a good taste. Later they
learned how to convert it into cheese, yogurt and so on (Metch-
nikoff and Mitchell, 1910; Metchnikoff, 2004; Amara, 2012).
Before the discovery of the microscope, humans knew how to
prepare different types of milk products with different tastes
and structures (Amara, 2012). This is a result of the action of
different microbial reactions induced by different microbes
(Bourdichon et al., 2012). The public, globally transfer such
information for producing such foods from generation to gen-
eration till today. We really did not know the starting point for
the ﬁrst use of food containing Probiotics particularly for
medicinal applications. However, by one way or the other Pro-
biotics collectively are a part of the fermented food if the active
microbes are useful and able to colonize the digestive system.
Fermentation using microbes is known from ancient times.
One could see the fungi growing in the food by the naked
eye. The public knew how to produce Bakery and alcoholic
products from times immemorial. They knew how to maintain
the product quality and testing by maintaining a seed culture
from the most successful fermentation processes to use in the
next process (Amara, 2012). However, scientists were interested
to give such honor to Van Leeuwenhoek and Hooke in 1665
(Gest, 2004). For more details about the fermented foods, refer
to Bourdichon et al. (2012) and the references within.
It might be that Probiotics have been discovered by the ﬁrst
human who used milk products, or, might be with substances
other than milk! such as the other different types of the fer-
mented foods. However, climatic conditions, for sure, favored
traditional sour milk or cultured dairy products such as Keﬁr,Koumiss, Leben and Dahi as claimed by Hosono (1992). Pub-
lic distribute stories about the origin of some types of Probio-
tics and that some have religious origin, such as the origin of
Keﬁer. Amara, 2012, describe some of the Probiotics used by
the Pharaonic civilization, which the Egyptians still use nowa-
days. They include milk, seeds, ﬁsh and some other products.
However, it might be that Ilya Ilyich Metchnikoff, the Nobel
Prize winner in Medicine in 1908, at the Pasteur Institute
was the ﬁrst who spotted the effect of what is called now Pro-
biotic. He linked the health and longevity to the ingestion of
bacteria present in yogurt (Metchnikoff and Mitchell, 1910;
Metchnikoff, 2004). In 1907, he postulated that bacteria were
involved in yogurt fermentation, Lactobacillus bulgaricus and
Streptococcus thermophilus, suppress the putrefactive-type fer-
mentations of the intestinal ﬂora and that consumption of
these yogurts was important in maintaining health. He corre-
lated the long life of Bulgarian peasants and their good health
to yogurt intake which contained the Lactobacillus species and
he simpliﬁed his conclusions to the public that, Probiotics
could do an extra-job by digesting unusual components exactly
like what happens in the ruminant animals which eat rough
food composed of bulky vegetables. In Japan, in the early
1930s, Shirota succeeded in isolating strains existing in healthy
individuals’ intestinal bacteria. Such strains are able to survive
and to passage through the gut. He has used such strains to de-
velop fermented milk and test such milk effects on patients. He
introduced his ﬁrst products into the market, which have been
given the name Shirota (later named Lactobacillus casei Shiro-
ta). The producer company’s name was the Yakult Honsha
Company. Probiotics can be deﬁned as living microorganisms
administered in an adequate number that continue to exist in
the intestinal bionetwork, to perform a health positive effect
(Gismondo et al., 1999). Probiotics as a term was ﬁrst used
by Lilly and Stillwell (1965) to describe the ‘substances secreted
by one microorganism that stimulate the growth of another’.
Parker (1974), proposed that Probiotics are ‘organisms and
substances which contribute to intestinal microbial balance’.
Food and Agriculture Organization of the United Nations/
World Health Organization (FAO/WHO, 2001) endorsed by
the International Scientiﬁc Association for Probiotics and
Prebiotics (Reid et al., 2003), deﬁned Probiotics as ‘Live
microorganisms which, when administered in adequate
amounts, confer a health beneﬁt on the host’.
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The microbes used as Probiotics represent different types
such as bacteria, yeast or mold. However, there are more
common species of each such as: 1 – Bacteria: (i) Lactobacil-
lus: acidophilus, sporogenes, plantarum, rhamnosum, del-
brueck, reuteri, fermentum, lactus, cellobiosus, brevis, casei,
farciminis, paracasei, gasseri, crispatus; (ii) Biﬁdobacterium:
biﬁdum, infantis, adolescentis, longum, thermophilum, breve,
lactis, animalis; (iii) Streptococcus: lactis, cremoris, alivarius,
intermedius, thermophilis, diacetylactis; (iv) Leuconostoc mes-
enteroides; (v) Pediococcus; (vi) Propionibacterium; (vii)
Bacillus; (viii) Enterococcus; (ix) Enterococcus faecium; 2 –
Yeast and molds: Saccharomyces cerevisiae, Saccharomyces
bourlardii, Aspergillus niger, Aspergillus oryzue, Candida pin-
tolopesii, Sacaromyces boulardii.
The type of the microbes used as Probiotics increased due
to the increase in the research concerning the subject as well
as by the increase of the newly discovered and identiﬁed mi-
crobes, which could be used as Probiotics. One should update
his microbial ﬂora from time to time and follow the research
and the published data about Probiotics to gain more knowl-
edge and ideas.
1.2. Probiotic for health improvement
One of the points described in this review about Probiotics is
their role in health improvement. In fact, this is the most
important point, where we expected that healthy persons will
be the ﬁrst in need to use Probiotics which will lead to improve
their general health and as a result will protect them from dif-
ferent kinds of illness. Improving health will be an intelligent
step for protecting us from different types of illness. Neverthe-
less, how could Probiotics do that? The following paragraphs
will highlight the concept of how Probiotics could improve
our health directly or indirectly.
1.3. Good and bad microbes
Our bodies have groups of microbes each working collec-
tively to perform different functions. The most important
ones are those existing in our digestive system (Gismondo
et al., 1999; Fioramonti et al., 2003). They improve food
digestion and consumption. They are able to complement
many deﬁciencies in our digestive system. They decrease
the steps needed in our bodies to change complicated food
structures to simpler ones. Alternatively, many bad variants
of different microbes will take their positions and will digest
our food incorrectly. They will even add some toxins to our
food during the digestive process. Hence, each food cycle
will lead to a real deterioration to our health (Amara,
2012). Many diseases are diagnosed incorrectly while their
main actual elevating purpose is due to the existence of
bad microbes in the digestive system, mainly due to the
leakage in the feeding processes, the life style or even dis-
eases which will direct the balance toward the bad microbes.
The affected ones are humans because they did not follow
the correct steps to protect themselves from losing the useful
strains and gaining harmful ones. In such cases, Probiotics
are needed to be given in higher dosages (Amara, 2012; Reid
et al., 2003).1.4. Probiotic, the good against the bad microbes
If harmful microbes colonized our digestive system they will
ferment food in incorrect ways and toxins, which will affect
our health, might be produced. What could Probiotics do? Pro-
biotics are able to regenerate our digestive system with good
microbes that will neutralize the harmful ones. Useful mi-
crobes will ferment our food correctly and improve our health.
Why must we use Probiotics? During our lives, we are exposed
to different types of microbes, which are unsuitable for our
health. Antibiotic treatment could destroy our useful micro-
ﬂora. In such cases, Probiotics should be used to regenerate
our microﬂora. If our daily food contains Probiotics, that will
be the best and the cheapest way to recover any losses in our
digestive system microﬂora and to improve our health. In old-
en civilizations, the public used to include food-containing
Probiotics in their daily food (Amara, 2012). However, when
our microﬂora has been affected severely due to any reasons,
Probiotics should be given in large dosage as tablets or in
any other suitable forms (Reid et al., 2003). A healthy intestine
is one that maintains a signiﬁcant balance of bacteria such as
lactobacilli, streptococci, clostridia, coliform, and bacteroides.
Conditions such as stress, excessive alcohol use, high fat diets,
meat, sugar, genetic disorders, chlorine and ﬂuoride in drink-
ing water, antibiotics, inadequate food, exposure to environ-
mental toxins and many others factors could change the
balance of our intestinal ﬂora (Hosono, 1992). In fact, our
health is affected by many exogenous and endogenous factors
that could change our microﬂora position. Useful microﬂora
guarantees good health. One cannot hear the sound of the dai-
ly battles between the good and the bad microbes in our bodies
or see how they enter our bodies with each breath, talk and
with each food consumed. Actually, they are essential for
our health. They build our immune system slowly to be ready
for the pathogens (Bandyopadhyay and Das Mohapatra, 2009;
Cammarota et al., 2009). Those that live far away from such a
lifestyle are more susceptible to infections and diseases
(Amara, 2012). Another side of the story, that such microbes
and mainly those which are non-pathogenic, are like workers
working in a big ﬁrm (our body), they do various jobs to sup-
port and assist us all the times. Mainly, they do that spontane-
ously. By doing such work, they save for us energy and power,
or they even do what we could not do. Complementing the
Lactose digestion deﬁciency is such an example (Hawrelak,
2003). The existence of harmful bacteria could ﬁnding resis-
tance in the body, so their negative effects might not appear di-
rectly, but after a considerable time. Alternatively, they are not
few in number but produced in considerable amounts, at this
point they will be really harmful (Amara, 2012). Bad microbes,
even though apparently non existant in a healthy person, actu-
ally, exist, but cannot do a lot of harm because of the existence
of good bacteria. They are under continuous pressure from
good bacteria. Good bacteria, ﬁll in the spaces existing in
our body, and prevent bad ones from taking their chances.
However, because of our misuse and misunderstanding of their
behavior, we change the conditions usually towards the beneﬁt
of bad bacteria. By changing the balance toward the bad mi-
crobes, we will start to suffer, and our health will start to de-
grade. To prevent that, the bad microbes should be kept
under control (Amara, 2012). Therefore, there is no better
solution other than, letting good ones compete with them, take
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the minimum safe amount. The intestinal tract is home to
one hundred trillion (1014) different types of microbe (Gis-
mondo et al., 1999). Many of the bad microbes like to live in
alkaline or natural environment, that is why our stomach is
acidic to kill most of them before they pass into the long intes-
tine. Bad microbes produce ammonia that change the intesti-
nal tract pH to becoming more alkaline (Metchnikoff and
Mitchell, 1910; Metchnikoff, 2004; Marteau et al., 2001).
One might observe that upon drinking fermented milk, which
is weakly acidic, he feels good and relaxed. This is because of
two factors, that fermented milk contains acids, which kill
pathogenic bacteria, and at the same time contains good bac-
teria, which will directly ﬁll the space of the just killed bacteria
(Fernandes et al., 1987; Hilton et al., 1977). Additionally, it
still contains proteins that are able to reduce any extra-acidity.
One of the most important strains existing naturally in milk
products is Lactobacillus. The microﬂora in our digestive sys-
tem do crucial jobs, such as ﬁlling in digestive system spaces,
food digestion, killing of pathogens, and secreting vitamins
(e.g. vitamin B) and some essential amino acids, enzymes help
in digesting complicated ﬁbers in the food, acid (e.g. lactic
acid) helps to prevent pathogenic microﬂora from exceeding
their number limit, and to perform many other vital activities.
As well, Probiotic strains found in the colon help in digesting
some forms of ﬁber. One should highlight that Probiotics are
also able to some extent activate the immune system (Camma-
rota et al., 2009).
1.5. The relation of Probiotics to our health could be summarized
in the following points and facts
1 – Probiotics are useful and friendly microbes.
2 – They are able to compete with the bad microbes and col-
onize our digestive system.
3 – They are able to ferment our food to simpler byproducts
and could promote our health by many different
mechanisms.
4 – Their amount could be deteriorated due to many fac-
tors, such as incorrect diet, alcohol, age and so on. This
is why they should be taken through our regular diet.
5 – In particular cases such as after antibiotic treatments,
where they are expected to be affected severely, they
should be taken orally in considerable amounts or with
food.
6 – Probiotics promote health while they:
a. Remove the side effect of the pathogens or the harmful
microbes.
b. Supply the body with useful byproducts.
c. Reduce the jobs of our digestive system.
d. Reduce the effect of the ﬁrst attack of harmful com-
pounds, instead of our cells, by their bioﬁlm, which pro-
tects our digestive system.
e. Reduce the amount of food needed by our bodies due to
the correct digestion and metabolism of any amount of
food.
f. Probiotics in some cases could complement the deﬁ-
ciency in our genetic materials by helping us to borrow
the products of their genes (such as in case of the lactose
fermentation deﬁciency).Here we should highlight that, Probiotics or anything in
our lives should not exceed a certain limit and should be
used wisely to give the best expected results (Salminen
et al., 1998).
1.6. Infection control
The mechanisms by which Probiotics exert their effects are lar-
gely unknown, and there are still many open research points.
However, Probiotics are involved in modifying gut pH, antag-
onizing pathogens through the production of antimicrobial
compounds, competing for pathogen binding and receptor
sites as well as for available nutrients and growth factors, stim-
ulating immunomodulatory cells, and producing lactase (Ta-
ble 1). The most important point of Probiotics is that they
are proven to be safe, cost effective, and could interfere with
the microbial infection. In 1994, the World Health Organiza-
tion deemed Probiotics to be the next-most important immune
defense system when commonly prescribed antibiotics are ren-
dered useless by antibiotic resistance (Kailasapathy and Chin,
2000; Levy, 2000). The use of Probiotics in antibiotic resistance
is termed as microbial interference therapy (Botes et al., 2008;
Fukao et al., 2009; Zhou et al., 2005).
2. Examples
2.1. Diarrheal diseases
Probiotics are proving to have roles in diarrhea prevention and
control after antibiotic treatment. Lactobacillus GG, Lactoba-
cillus reuteri, and S. boulardii, Biﬁdobacteria spp., are used
for curing diarrhea (Hilton et al., 1977; Isolauri, 2004; Benchi-
mol and Mack, 2004). Also Probiotics are able to suppress
travelers’ diarrhea (Hilton et al., 1977) and diarrheal diseases
in young children caused by rotaviruses (Saavedra et al.,
1994; Vanderhoof, 2000). The Probiotic species used with chil-
dren include Lactobacillus spp., L. reuteri, Lactobacillus casei,
S. boulardii, Biﬁdobacterium biﬁdum and S. thermophilus (Hil-
ton et al., 1977; Tomas et al., 2004). Probiotics might prevent
microbes that carry diarrhea by competing with pathogenic
viruses or bacteria by preventing them from binding to epithe-
lial cells (DeSimone, 1986; O’Sullivan et al., 1992), or by pro-
ducing bacteriocins such as nisin (del Miraglia and De Luca,
2004).
2.2. Helicobacter pylori infections
Aiba et al. (1998) showed Lactobacillus salivarius capable of
producing high amounts of lactic acid, which can inhibit
the growth of H. pylori in vitro. There is some preliminary
evidence that Probiotic bacteria may inhibit the gastric colo-
nization and activity of H. pylori, which is associated with
gastritis, peptic ulcers and gastric cancer. L. salivarius was
found to inhibit H. pylori colonization in the in vitro studies
as well as in mice (Aiba et al., 1998; MacFarlane and Cum-
mings, 2002). The use of Probiotics in the ﬁeld of H. pylori
infection has been proposed for improving the eradication
rate and tolerability and for the compliance of multiple anti-
biotic regimens used for the infection (Bazzoli et al., 1992; Fi-
lippo et al., 2001).
Table 1 Different types of Probiotic microbial strains, and their usage.
Disease name Strain References
Eczema Escherichia coli
Biﬁdobacterium biﬁdum
Biﬁdobacterium lactis
Lactococcus lactis
Niers et al. (2009), Soh et al. (2009),
Viljanen et al. (2005a and 2005b)
Food allergies Escherichia coli Lodinova-Zadnikova et al. (2003)
Immunity Bacillus circulans PB7
Lactobacillus plantarum
DSMZ 12028
Bandyopadhyay and Das Mohapatra
(2009) and Cammarota et al. (2009)
Antibiotic eﬀect removal Enterococcus mundtii ST4SA
Lactobacillus plantarum 423
Lactobacillus brevis KB290
Lactobacillus strains
Biﬁdobacterium strains
Botes et al. (2008), Fukao et al. (2009) and
Zhou et al. (2005)
Gastroenteritis
Therapeutics
Lactobacillus casei Yamada et al. (2009)
Intestinal
hyperpermeability
Lactobacillus plantarum species
299 (LP299)
Kennedy et al. (2000), Strowski and
Wiedenmann (2009) and White et al. (2006)
Vaginal candidiasis
(thrush)
Lactobacillus rhamnosus GR-1
Lactobacillus reuteri RC-14
Martinez et al. (2009)
Urinary tract infection Lactobacillus rhamnosus GR-1
Lactobacillus reuteri RC-14
Anukam et al. (2009)
Lactose intolerance Lactobacillus acidophulus Hawrelak (2003)
Non-steroidal anti-
inﬂammatory drug
Escherichia coli strain Nissle
1917
Ukena et al. (2005)
Intestinal dysbiosis Lactobacillus johnsonii La1
Lactobacillus strain
Lactobacillus GG
Hawrelak (2003), Silva et al. (1987), and
Bennett et al. (1996)
Irritable bowel syndrome Biﬁdobacterium infantis 35624
Escherichia coli DSM17252
Biﬁdobacterium infantis 35624
Brenner and Chey (2009), Enck et al.
(2009), Whorwell et al. (2006)
Traveler’s diarrhea Lactobacillus GG
Lactobacillus plantarum
Hawrelak (2003), and Michail and
Abernathy (2002)
Radiation-induced
diarrhea
Lactobacillus casei DN-114 001 Giralt et al. (2008)
Crohn’s disease Escherichia coli strain Nissle
1917
Boudeau et al. (2003)
Prevention of colon cancer Enterococcus faecium M-74
lactic acid bacteria
Mego et al. (2005) and Thirabunyanon
et al. (2009).
Ulcerative colitis Lactobacillus acidophilus
Escherichia coli Nissle 1917
Biﬁdobacterium
Abdin and Saeid (2008), Adam et al.
(2006), and Imaoka et al. (2008)
Peptic ulcer disease Lactobacillus acidophulus Iarovenko et al. (2007)
Prevention of atopy Lactobacillus rhamnosus GG Huurre et al. (2008) and van der Aa et al.
(2008)
Hypercholesterolemia and
cardiovascular diseases
Enterococcus faecium M-74
Lactobacillus plantarum
Propionibacterium
freudenreichii
Lactobacillus plantarum PH04
Hlivak et al. (2005), Kiatpapan et al. (2001)
and Nguyen et al. (2007)
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Probiotics could not only improve our health or control path-
ogenic infections but could also help in real disease treatment
and management (Table 1). Part of the basis for doing such
tasks is based on the same concepts about Probiotic functions,
which are described in the above sections. But, how could
Probiotics help in real disease treatment and management.
The most critical points are in understanding of the disease
behavior and its causative agents. For examples, diseases
which are related to genetic disorders, will cause certain sortof deﬁciencies like lactose intolerance. The role of Probiotics
in such types of cases will be in removing such deﬁciencies
by different mechanisms such as (i) supplying our bodies with
the products of the missed gene products, (ii) supplying our
bodies with suitable alternative products, (iii) supplying our
bodies with the ﬁnal products of a complete pathway which
will be the best choice and in the case that none of the defective
pathway metabolic intermediates will be accumulated in our
cells in the case of a single or multiple gene deﬁciency which
could block a certain pathway, (for more details refer to
Amara, 2013 and the references within), (iv) Probiotics could
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pathway which might be due to a defect in a single allele rather
than the defect in both alleles. Exactly like in the case of those
who have retinoblastoma. In such a case the critical basis for
the Knudson hypnosis’s will be completely interfered with
while a single gene will not be a subject to excessive stress that
could lead to a mutation (Amara, 2013), (v) Probiotics will be
the best support for us when we become old. It will reduce the
load on our biological system and will enable us to do extra
activity, particularly those related to improving our ability to
utilize food. Here are some roles for Probiotics in maintaining
our health, in disease treatment and management:
1 – Suppression of the putrefactive-type fermentation which
was one of the Ilya Ilyich Metchinkoff postulations
about the usefulness of Probiotics (Metchnikoff, 2004).
2 – Used to reduce the antibiotic destructive effect and to
regenerate any type of loss in beneﬁcial microﬂora.
Some Bacillus species are recommended for use with
antibiotics while they are resistant to them (Bandyopad-
hyay and Das Mohapatra, 2009; Cammarota et al.,
2009).
3 – Treating of the diarrheal disorder. Saccharomyces cere-
visiae var boulardii was used widely for treating various
diarrheal disorders (Hawrelak 2003; Michail and Abern-
athy, 2002).
4 – Improving intestinal tract health (Vanderhoof, 2000).
5 – Enhancing the immune system, synthesis and enhancing
the bioavailability of nutrients (MacFarlane and Cum-
mings, 2002).
6 – Reducing symptoms of lactose intolerance and decreas-
ing the prevalence of allergy in susceptible individuals
(Hawrelak, 2003).
7 – Reducing the risk of certain cancers (Mego et al., 2005;
Thirabunyanon et al., 2009).
8 – Control of serum cholesterol levels (Hlivak et al., 2005).
9 – Improved digestion of lactose against foods containing
lactose.
10 – Probiotics may also inﬂuence the protective functions of
the intestinal mucosa including the synthesis and secre-
tion of antibacterial peptides (Cammarota et al., 2009).
11 – Hypertension (Blood pressure control) (Hlivak et al.,
2005).
12 – Condition of the genitourinary tract (Martinez et al.,
2009).
3. Conclusion
The health condition of the mother and the environment where
the child is born determines the ﬁrst species which colonizes his
body and which affects his health during his life. Good micro-
bial strain colonies of microﬂora will lead to good health and
will give us different types of beneﬁt. In our life, there are
many factors that disturb our useful microﬂora, in these con-
ditions exo-sources should be used. Such exo-sources which
contain such useful microbes or what is named Probiotics
could exist in many types of foods, fermented foods, milk
and milk products. Also, science, the scientist and the modern
companies provide us with different forms of Probiotics for
different types of illness. The early human observations, theresearchers and the different applications for Probiotics in
their different forms highlight how much such wonderful mi-
crobes could do to promote our health, protect us and ensure
treatment or management of diseases. Perhaps the most critical
point of Probiotics, is that they come in natural forms and per-
form natural safe activities. This review, gives a compact col-
lection of the different strains of probiotics, types,
applications and some of the involved companies in such ﬁelds
as well as the names of the same types of foods rich in Probi-
otics. The future will show increasing interest in Probiotics, the
promising microbes.
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